Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Self glycolipids as T-cell autoantigens.

A Shamshiev1, A Donda, I Carena

  • 1Department of Research, University Hospital Basel, Switzerland.

European Journal of Immunology
|June 8, 1999
PubMed
Summary

New research reveals that glycolipids, not just proteins, are recognized by T cells in multiple sclerosis (MS) patients. These T cells, reactive with glycolipids, are more frequent in MS, suggesting glycolipids as potential autoimmune targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An R tool for computing and evaluating Fuzzy poverty indices: The package FuzzyPovertyR.

Journal of applied statistics·2025
Same author

Five-year recurrence after endoscopic approach to pilonidal sinus disease: A multicentre experience.

Techniques in coloproctology·2023
Same author

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.

Journal of neurology·2023
Same author

Fully Automatic Method for Reliable Spinal Cord Compartment Segmentation in Multiple Sclerosis.

AJNR. American journal of neuroradiology·2023
Same author

Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentials.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2022
Same author

Clinical and dermoscopic changes of acquired melanocytic nevi of patients treated with afamelanotide.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2021

Area of Science:

  • Immunology
  • Neuroscience
  • Biochemistry

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease.
  • Autoimmune responses against myelin components are implicated in MS pathogenesis.

Purpose of the Study:

  • To identify novel autoantigens recognized by T cells in multiple sclerosis patients.
  • To investigate the role of glycolipids as potential targets in MS autoimmunity.

Main Methods:

  • Enzyme-linked immunospot (ELISPOT) assay to detect T cell reactivity.
  • Characterization of T cell responses to various glycolipids (gangliosides, sulfatide, galactosylceramide).
  • Analysis of T cell surface markers (CD8, TCR alphabeta) and MHC restriction (CD1b).

Main Results:

Related Experiment Videos

  • Circulating T cells reactive to glycolipids are significantly more frequent in MS patients compared to healthy controls.
  • These T cells recognize diverse glycolipids and release inflammatory cytokines (IFN-gamma, TNF-alpha).
  • Ganglioside-specific T cells are CD8+, TCR alphabeta+, restricted by CD1b, and target the carbohydrate portion of gangliosides.

Conclusions:

  • Self-glycolipids, in addition to self-proteins, represent potential autoantigens in autoimmune diseases like MS.
  • This finding expands the understanding of autoimmune targets in neuroinflammation.
  • Glycolipid-reactive T cells may play a role in the pathogenesis of multiple sclerosis.